|
|
|
40
|
01133
|
CEFAZOLIN 1G IV/IM INJ (RTM/PHA)
|
CEFAZOLIN
|
CEFAZOLIN
|
1G VIAL
|
B
|
3.89
|
3.89
|
INJECTION
|
0
|
VIAL
|
RTM
|
PANPHARMA GMBH
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
08120604
|
FIRST GEN CEPHALOSPORINS
|
2022-04-01
|
2024-03-31
|
|
IV/IM
|
6
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
41
|
01133
|
CEFAZOLIN 1G IV/IM INJ (RTM) (BQ)
|
CEFAZOLIN
|
CEFAZOLIN
|
1G VIAL
|
BQ
|
3.97
|
3.9688
|
VIAL
|
10
|
VIAL
|
RTM
|
PANPHARMA GMBH
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
08120604
|
FIRST GEN CEPHALOSPORINS
|
2024-04-01
|
2026-03-31
|
|
IV/IM
|
0
|
FIRST GEN CEPHALOSPORINS
|
|
|
|
|
40
|
0164C
|
AMPICILLIN 500MG INJ (RTM/PHA)
|
AMPICILLIN
|
AMPICILLIN
|
500MG VIAL
|
C
|
1.82
|
1.82
|
INJECTION
|
0
|
VIAL
|
RTM
|
PANPHARMA GMBH
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
081216
|
PENICILLINS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
41
|
0164C
|
AMPICILLIN 500MG INJ (RTM) (BQ)
|
AMPICILLIN
|
AMPICILLIN
|
500MG VIAL
|
BQ
|
2.36
|
2.3649
|
VIAL
|
28
|
VIAL
|
RTM
|
PANPHARMA GMBH
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
081216
|
PENICILLINS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
PENICILLINS
|
|
|
|
|
40
|
01916
|
PENICILLIN G SODIUM 1MU INJ (RTM/PHA)
|
PENICILLIN G SODIUM
|
PENICILLIN G SODIUM
|
15ML
|
B
|
12.07
|
12.07
|
INJECTION
|
0
|
VIAL
|
RTM
|
PANPHARMA GMBH
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
081216
|
PENICILLINS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
41
|
01916
|
PENICILLIN G SODIUM 1MU INJ (RTM) (B)
|
PENICILLIN G SODIUM
|
PENICILLIN G SODIUM
|
15ML
|
B
|
11.5
|
11.4985
|
VIAL
|
0
|
VIAL
|
RTM
|
PANPHARMA GMBH
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
081216
|
PENICILLINS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
PENICILLINS
|
|
|
|
|
40
|
01924
|
PENICILLIN G SODIUM 5MU INJ (RTM/PHA)
|
PENICILLIN G SODIUM
|
PENICILLIN G SODIUM
|
15ML
|
B
|
12.07
|
12.07
|
INJECTION
|
0
|
VIAL
|
RTM
|
PANPHARMA GMBH
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
081216
|
PENICILLINS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
40
|
0212BG
|
MEROPENEM 1G INJ (RTM/PHA)
|
MEROPENEM
|
MEROPENEM
|
20ML VIAL
|
BQ
|
14.79
|
14.79
|
INJECTION
|
0
|
VIAL
|
RTM
|
PANPHARMA GMBH
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
08120708
|
CARBAPENEMS
|
2022-04-01
|
2024-03-31
|
|
IV
|
6
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
40
|
0321AB
|
GENTAMICIN 40MG/ML IV/IM INJ (RTM/PHA)
|
GENTAMICIN
|
GENTAMICIN
|
10X2ML
|
B
|
12.48
|
1.25
|
INJECTION
|
0
|
AMP
|
RTM
|
PANPHARMA GMBH
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
081202
|
AMINOGLYCOSIDES
|
2022-04-01
|
2022-05-31
|
|
IV/IM
|
6
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
40
|
0321AB
|
GENTAMICIN 40MG/ML IV/IM INJ (RTM/PHA)
|
GENTAMICIN
|
GENTAMICIN
|
10X2ML
|
B
|
19.27
|
1.93
|
INJECTION
|
0
|
AMP
|
RTM
|
PANPHARMA GMBH
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
081202
|
AMINOGLYCOSIDES
|
2022-06-01
|
2024-03-31
|
Price Change
|
IV/IM
|
6
|
ANTI-INFECTIVE AGENTS
|
2022-05-31
|
|
|
|
41
|
0321AB
|
GENTAMICIN 40MG/ML IV/IM INJ (RTM) (B)
|
GENTAMICIN
|
GENTAMICIN
|
10X2ML
|
B
|
14.9
|
1.4896
|
AMP
|
0
|
BOX
|
RTM
|
PANPHARMA GMBH
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
081202
|
AMINOGLYCOSIDES
|
2024-04-01
|
2026-03-31
|
|
IV/IM
|
0
|
AMINOGLYCOSIDES
|
|
|
|
|
40
|
0752F
|
BUTYLSCOPOLAMINE 20MG/ML INJ (RTM/PHA) HYOSCINE BUTYLBROMIDE
|
HYOSCINE BUTYLBROMIDE
|
BUTYLSCOPOLAMINE
|
10X1ML
|
B
|
18.92
|
1.89
|
INJECTION
|
0
|
AMP
|
RTM
|
PANPHARMA GMBH
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
120808
|
ANTIMUSCARINICS/ANTISPASMODICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
AUTONOMIC DRUGS
|
|
|
|
|
41
|
0752F
|
BUTYLSCOPOLAMINE 20MG/ML INJ (RTM) HYOSCINE BUTYLBROMIDE (B)
|
HYOSCINE BUTYLBROMIDE
|
BUTYLSCOPOLAMINE
|
10X1ML
|
B
|
19.33
|
1.9327
|
AMP
|
20
|
BOX
|
RTM
|
PANPHARMA GMBH
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
120808
|
ANTIMUSCARINICS/ANTISPASMODICS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
ANTIMUSCARINICS/ANTISPASMODICS
|
|
|
|
|
40
|
07918
|
ADRENALINE 1MG/ML IV/IM INJ (RTM/PHA)
|
ADRENALINE
|
ADRENALINE
|
10X1ML
|
B
|
35.01
|
3.50
|
INJECTION
|
0
|
AMP
|
RTM
|
PANPHARMA GMBH
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
121212
|
ALPHA & BETA ADRENERGIC AGONIST
|
2022-06-01
|
2024-03-31
|
Price Change
|
IV/IM
|
0
|
AUTONOMIC DRUGS
|
2022-05-31
|
|
|
|
40
|
07918A
|
ADRENALINE 1MG/ML IV/IM INJ (RTM/PHA)
|
ADRENALINE
|
ADRENALINE
|
10X1ML
|
B
|
24.14
|
2.41
|
INJECTION
|
0
|
AMP
|
RTM
|
PANPHARMA GMBH
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
121212
|
ALPHA & BETA ADRENERGIC AGONIST
|
2022-04-01
|
2022-05-31
|
|
IV/IM
|
0
|
AUTONOMIC DRUGS
|
|
|
|
|
41
|
08011
|
DOPAMINE 40MG/ML INJ (RTM) (B)
|
DOPAMINE
|
DOPAMINE
|
10X5ML
|
B
|
114.5
|
11.4496
|
AMP
|
0
|
BOX
|
RTM
|
PANPHARMA GMBH
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
121208
|
BETA ADRENERGIC AGONIST
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
BETA ADRENERGIC AGONIST
|
|
|
|
|
40
|
0941F
|
PANCURONIUM BROMIDE 2MG/ML INJ (RTM/PHA)
|
PANCURONIUM BROMIDE
|
PANCURONIUM BROMIDE
|
5X2ML
|
BQ
|
40.23
|
8.05
|
INJECTION
|
0
|
AMP
|
RTM
|
PANPHARMA GMBH
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
122020
|
NEUROMUSCULAR BLOCKING AGENTS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
AUTONOMIC DRUGS
|
|
|
|
|
41
|
0941F
|
PANCURONIUM BROMIDE 2MG/ML INJ (RTM (B)
|
PANCURONIUM BROMIDE
|
PANCURONIUM BROMIDE
|
5X2ML
|
B
|
114.63
|
22.9263
|
AMP
|
0
|
BOX
|
RTM
|
PANPHARMA GMBH
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
122020
|
NEUROMUSCULAR BLOCKING AGENTS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
NEUROMUSCULAR BLOCKING AGENTS
|
|
|
|
|
40
|
1011J
|
HEPARIN 5000U/ML INJ (RTM/PHA)
|
HEPARIN
|
HEPARIN
|
5ML VIAL
|
B
|
12.23
|
12.23
|
INJECTION
|
0
|
VIAL
|
RTM
|
PANPHARMA GMBH
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
20120416
|
HEPARINS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
BLOOD FORMATION, COAGULATION AND THROMBOSIS
|
|
|
|
|
41
|
1011J
|
HEPARIN 5000U/ML INJ (RTM) (B)
|
HEPARIN
|
HEPARIN
|
5ML VIAL
|
B
|
15.39
|
15.3857
|
VIAL
|
0
|
VIAL
|
RTM
|
PANPHARMA GMBH
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
20120416
|
HEPARINS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
HEPARINS
|
|
